Pineal Gland Abstracts
January - June 2005
 
 

Note: the following is a limited selection of abstracts available at PubMed, Science Direct, and Toxnet.

Abstracts on the Pineal Gland by Year
-
2005
(Jan-June)

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16011484&query_hl=1

J Neuroendocrinol. 2005 Aug;17(8):483-8.

Perinatal influences of melatonin on testicular development and photoperiodic memory in siberian hamsters.

Tuthill CR, Freeman DA, Butler MP, Chinn T, Park JH, Zucker I.

Department of Psychology, University of California, Berkeley, CA, USA.

We assessed the influence of perinatal melatonin on reproductive development and adult responsiveness to melatonin. Testicular growth in an intermediate day length (14 : 10 h light/dark cycle) was substantially reduced in Siberian hamsters gestated by pinealectomised compared to pineal-intact females; gonadal development was normalised in offspring of pinealectomised dams that were pinealectomised at 3-4 days of age. Hamsters deprived of melatonin only during gestation, or both pre- and postnatally, underwent testicular involution during treatment with melatonin in adulthood. Photoperiodic histories acquired prenatally did not endure as long as those acquired by adult hamsters. Hamsters first exposed to melatonin in adulthood were not more proficient in acquiring photoperiodic histories than were normal males. These findings indicate that pre- versus postnatal differences in melatonin signal duration determine rates of testicular development. Exposure to melatonin perinatally does not appear to organise the neuroendocrine substrate that mediates effects of day length and melatonin on the gonads of adult hamsters.

PMID: 16011484 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16048636&query_hl=6

Int J Androl. 2005 Aug;28(4):234-40.
 
Altered melatonin secretion in hypogonadal men: clinical evidence.

Kumanov P, Tomova A, Isidori A, Nordio M.

Clinical Center of Endocrinology, Medical University, Sofia, Bulgaria.

Summary The pineal gland, through the rhythmic production of melatonin, seems to play an important role in the control of the reproductive function of many vertebrate species. In contrast, the effects of the pineal gland in humans and the relationship between gonadotropins and melatonin secretion are not yet clarified. On the basis of these considerations, the aim of the present study was to clarify whether melatonin serum concentrations were altered in males with different hypothalamo-pituitary-gonadal disturbances, in comparison to normal individuals. We have studied 36 individuals divided into three groups according to their gonadotropin status: normals, hypogonadotropic hypogonadism and hypergonadotropic hypogonadism. They were submitted to blood sample withdrawal at 03.00, 11.00 and 19.00 h for melatonin determination according to a radioimmunological method, without extraction of the sample. The results obtained in the present study suggest the existence of an interaction between the pituitary and the pineal gland. In fact, in the case of hypersecretion of gonadotropins, nocturnal melatonin release is reduced, while night melatonin secretion is increased in the opposite situation (hypogonadotropic hypogonadism). Both these endocrine pathologies are characterized by a reduced sexual steroid secretion; for that reason, this reduction cannot be regarded as responsible for the two opposite dysfunctions of melatonin release. In conclusion, our study shows that darkness-dependent release of melatonin in males with hypogonadotropic hypogonadism is significantly higher in comparison with the healthy men, while it is significantly reduced in patients with hypergonadotropic hypogonadism. A strong significant negative correlation is also found between gonadotropins and melatonin release.

PMID: 16048636 [PubMed - in process]


http://www.newsday.com/

Newsday (New York)

July 20, 2005

Study finds higer cancer rates in night shift workers

Linking nighttime work to tumors
Melatonin impedes breast cancer growth but night shift keeps its levels too low to be effective, says report


BY DELTHIA RICKS
STAFF WRITER

Night shift workers who had low levels of the body's vital "sleep hormone," were significantly more likely to develop breast cancer than those who were awake during the day but who got plenty of shuteye at night, a team of scientists report today.

The analysis by Boston researchers goes straight to the heart of a question scientists have asked for years: Are night shift workers, because of extended exposure to artificial light, more likely to develop cancer?

"Two or three years ago we probably would have been reluctant to say there was an association," said Dr. Eva Schernhammer, an epidemiologist at Brigham and Women's Hospital. "But now the evidence is becoming clearer," that a relationship exists between tumor development and being exposed to light at night, she said.

"This study brings us one step closer to understanding why night shift workers may be more likely to develop breast cancer."

During daylight or exposure to bright lights, the hormone melatonin is suppressed. Switch off the lights and melatonin, secreted by the brain's pineal gland, begins to stream into the blood. The hormone flows most copiously during sleep, thus its nickname, the sleep hormone.

A growing number of scientists theorize that melatonin also suppresses the growth of cancer cells.

Laboratory studies by researchers at the University of Arizona have shown that breast cancer cells stop proliferating in melatonin's presence. And Dr. David Blask of the Bassett Research Institute in Cooperstown found that melatonin serves as an anticancer signal to human breast cancers.

Schernhammer, who reported her results in today's Journal of the National Cancer Institute, said women exposed to light at night had measurably lower levels of a melatonin breakdown product in urine.

In her analysis, which involved participants from the Nurses Health Study, urine samples were taken from 147 nurses with invasive breast cancer and 291 matched controls who did not have the disease.

The lowest levels of melatonin's breakdown product were in night shift workers who had developed the cancer, leading Schernhammer to conclude that women with the lowest levels were 70 times more likely to develop breast cancer.

"This is an interesting bit of new information and it will be put in context with other studies that have shown similar results and those that have shown no association," said Dr. Brian O'Hea, director of the Carol M. Baldwin Breast Care Center at Stony Brook University Hospital.

To further test her theory about light exposure and breast cancer, Schernhammer has embarked on a study of blind women, whose eyes aren't transmitting light to the brain. Thus she hypothesizes they have lower rates of breast cancer and higher levels of circulating melatonin.

Copyright 2005 Newsday Inc.

 

From Science Direct

Behavioural Brain Research - 2005 - Volume 160, Issue 1 , 7 May 2005, Pages 148-16

The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function

Gregory L. Willis

The Bronowski Institute of Behavioural Neuroscience, Coliban Medical Centre, 19 Jennings Street, Kyneton 3444, Vic., Australia

There are reports that melatonin secretion from the pineal gland gradually diminishes with advancing age. It has been suggested that various forms of neuropsychiatric disease, in particular, Parkinson's disease (PD), is consequentially related to this decrease by virtue of increased oxidative stress which enhances the process of dopamine (DA) degeneration. There is, however, considerable disagreement on this theme as very little is generally known about the role of the pineal gland in the aetiology and treatment of PD. To assess the role of the pineal gland in PD and in dopamine replacement therapy (DART), the effect of three anti-Parkinsonian drugs on motor and psychiatric function was assessed in normal, pinealectomized (PX) and DA deficient, PX rats. In the first study, rats underwent PX or sham operation and were then injected (IP) with Amantadine (30 or 50 mg/kg), Bromocriptine (5 or 10 mg/kg) or L-Dopa (30 or 60 mg/kg plus 50 mg/kg of R-044602) 3–8 weeks after surgery. Open field performance and motor reflex tests were assessed during the light and dark phases of the L/D cycle. In a second study, clinically effective doses of Bromocriptine (10 mg/kg) and L-Dopa (30 and 100 mg/kg with 50 mg/kg R-044602) were injected into depleted, PX or sham operated rats. In study I, sham operated and PX rats responded differently to Bromocriptine and L-Dopa, while Amantadine did not differentially effect motor performance in the two groups. In study II, 6-OHDA induced degeneration of the nigro-striatal system abolished the effects of Bromocriptine and dramatically altered the effects of L-Dopa seen in study I, in sham operated versus PX rats. DART significantly altered emotionality, as measured by escape attempts, agitation and rage in sham operated animals, compared to PX rats. DA deficiency abolished the tendency to escape in all groups except those treated with 100 mg/kg of L-Dopa. Conversely, agitation and rage scores were greater after 100 mg/kg of L-Dopa, in rats with intact pineal function, than in PX rats. These results provide compelling evidence that altered pineal function plays a major role in the aetiology of PD, the therapeutic effect of anti-Parkinsonian drugs and in the psychiatric side effects of DART.



Trends in Pharmacological Sciences
Volume 26, Issue 8 , August 2005, Pages 412-419

Molecular tools to study melatonin pathways and actions

Jean A. Boutina (a), Valérie Audinot (a), Gilles Ferry (a) and Philippe Delagrange (b)

(a) Pharmacologie Moléculaire et Cellulaire, Institut de Recherches Servier, 125, chemin de Ronde 78290 Croissy-sur-Seine, France
(b) Département des Sciences Expérimentales, Institut de Recherches Servier, 11, rue des Moulineaux, 92150 Suresnes, France

Melatonin, an indoleamine neurohormone that is synthesized mainly in the pineal gland and derived from 5-HT, has many effects on a wide range of physio-pathological functions. Some of these effects are mediated by the interactions of melatonin with the two melatonin MT1 and MT2 receptors. Other effects are often suggested to be due to the chemical antioxidant nature of this indoleamine, and are observed at high, non-physiological concentrations. However, it is increasingly believed that some of these effects are due to interactions with other protein targets. In this review, we summarize the molecular pharmacology of melatonin, including the main enzymes involved in its synthesis and catabolism, and the proteins that mediate its actions. Furthermore, various compounds, mainly inhibitors and antagonists, that can be used to dissect these functions and pathways are presented.

Excerpt:
Melatonin: a pharmacological agent with a plethora of actions
Melatonin is a neurohormone that is synthesized in the pineal gland. Its production is controlled through the suprachiasmatic nucleus by the photoperiod (i.e. the succession of nights and days). Melatonin relays the information about this photoperiod to the tissues that express melatonin binding sites in both central and peripheral nervous systems. Melatonin has been claimed to exert many functions (Box 1). However, in humans, appropriate clinical trials have confirmed the efficacy of melatonin only in circadian-rhythm sleep disorders. An animal model is considered to be relevant for human pathology only if it has been validated by drugs for which their efficacy has been demonstrated in clinical trials. Results of preclinical studies in such validated animal models suggest that other therapeutic options exist for melatonin [1], particularly in wake–sleep disorders, depression and aging. Indeed, a novel treatment of depression that involves a melatonin component has been proposed recently and validated clinically with Agomelatine®, a dual melatonin MT1–MT2 receptor agonist and 5-HT2C receptor antagonist [2]. The main curiosity associated with the wide range of proposed functions of melatonin is the concentration at which melatonin is active. Depending on its actions, melatonin is reportedly active at concentrations ranging from subnanomolar to millimolar doses, although melatonin circulates at a nightly peak concentration in the low nanomolar range (0.3 nM).

Box 1

Recently reported effects of melatonin
• Corrects disrupted circadian rhythms
• Modulates neuronal activity in the rat hippocampus
• Has anticonvulsant activity in electroshock seizures
• Regulates cerebral blood flow in rats
• Is a hypotensive factor in rats
• Potentiates noradrenergic-mediated vasoconstriction (through MT1 receptors) and mediates vasodilatation (through MT2 receptors) of rat caudal artery
• Inhibits leukocyte rolling in the rat microvasculature
• Inhibits nitrate tolerance in rat arteries
• Has a protective effect on myocardial infarction
• Prevents necrotic cell death and renal dysfunction after ischaemia–reperfusion if given as a pretreatment
• Reduces body weight gain of overweight rats
• Inhibits spinal cord synaptic potentiation
• Inhibits the effects of estrogen
• Stimulates cell proliferation in zebrafish
• Increases duodenal bicarbonate secretion release in rats
• Enhances lymphocyte proliferation
• Has an analgesic effect

... Concluding remarks
In most cases, a molecule is not an actual target in the search for drugs. However, there are >11 200 citations related to melatonin in PubMed®, which highlight the fascinating characteristics of melatonin. Melatonin has been described as having an effect in almost all the main physiological functions of the body. Thus, its molecular targets are of particular interest. Indeed, it is difficult to believe that two seven-transmembrane receptors and one enzyme are the sole proteins through which this pineal hormone exerts its effects. Furthermore, the discovery of the third site, QR2, added many questions to the list, instead of solving problems. Functions that involve the melatonin pathway are shown in Box 2.

Box 2
Expected effects of pharmacologically modifying the melatonin pathway(s)
Actions through MT1 receptor activation
• Inhibition of neuronal firing rate in the suprachiasmatic nucleus
• Inhibition of the cAMP response element-binding protein phosphorylation in the suprachiasmatic nucleus
• Inhibition of the prolactin secretion from the pars tuberalis
• Induction of vasoconstriction of rat caudal artery
Actions through MT2 receptor activation
• Induction of phase shifts in suprachiasmatic nucleus circadian rhythms
• Inhibition of dopamine release in the retina
• Induction of vasodilatation of rat caudal artery
• Increase in splenocyte proliferation
• Inhibition of leukotriene B4-induced leukocyte adhesion
Actions through the inhibition of AANAT
• Loss of melatonin synthesis
• Concomitant gain in serotonin level
Actions through the association with MT3/QR2
• Protection against a potential toxification mechanism (similar to resveratrol?)
Actions of idoleamine-2,3-dioxygenase and myeloperoxidase
• Production of melatonin metabolites suspected to be pharmacologically active (e.g. kynurenines)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15978060&query_hl=1

Pineal Res. 2005 Aug;39(1):73-6.
 
Serum melatonin circadian profiles in women suffering from cervical cancer.

Karasek M, Kowalski AJ, Suzin J, Zylinska K, Swietoslawski J.

Chair of Pathomorphology, Department of Electron Microscopy, Polish Mother's Memorial Hospital-Research Institute, Medical

University of Lodz, Lodz, Poland.

Although there is an increasing evidence that the pineal gland may play a role in human malignancy, the studies on melatonin concentrations in different types of malignant tumors brought about controversial results. However, changes in melatonin concentrations have been observed in some types of human malignant tumors. Therefore, we decided to study the circadian melatonin rhythm in patients suffering from cervical cancer in different stages of progression and to compare them with those in subjects free from neoplastic disease. A total of 45 women were analyzed in this study. The subjects were divided into two groups. The first group consisted of 31 patients [mean age 52.1 +/- 1.8 yr (mean +/- S.E.M.), range 32-77 yr] with cervical cancer in various stages of the disease. The second group consisted of 14 healthy volunteers [mean age 53.5 +/- 2.0 yr (mean +/- S.E.M.), range 42-63] who served as the control group. Blood samples were collected at 08:00, 12:00, 16:00, 20:00, 22:00, 24:00, 02:00, 04:00, 06:00, and 08:00 hours. Melatonin concentration was measured by immunoenzymatic method. There were significant differences in circadian melatonin profiles as well as in the area under curve among the two studied groups. Melatonin concentrations were significantly lower in cancer patients in comparison with healthy individuals. Taking into consideration stage of the cervical cancer significantly lower melatonin secretion has been found in all subgroups of patients in comparison with that of tumor-free control group. Additionally, nocturnal melatonin concentrations as well as area under curve were significantly lower in advanced stage of cancer (stages 3 and 4) in comparison with patients with preinvasive cancer (stage 0) at 24:00, 02:00, and 04:00 hours and patients with stage 1 disease at 02:00 and 04:00 hours. The results of the present study indicate that the presence of cervical cancer influences melatonin levels in women. Moreover, stage dependence in reduction of melatonin concentrations has been found.

PMID: 15978060 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15926922&query_hl=4

Eur J Neurosci. 2005 May;21(10):2743-51.
 
Tachykinins and tachykinin-receptors in the rat pineal gland.

Mukda S, Chetsawang B, Govitrapong P, Schmidt PT, Hay-Schmidt A, Moller M.

Institute of Medical Anatomy, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.

High-pressure liquid chromatography of extracts of rat pineal glands, followed by radio immunological analysis with antibodies against tachykinins, demonstrated the presence of substance P, neurokinin A and neurokinin B in the superficial rat pineal gland. Immunohistochemistry on perfusion-fixed rat brain sections showed substance P and neurokinin A to be present in nerve fibers located both in the perivascular spaces as well as intraparenchymally between the pinealocytes. After extracting total RNA, followed by reverse transcription and polymerase chain reaction amplification with primers specific for NK1-, NK2- and NK3-receptors, agarose gel analysis of the reaction products showed the presence of mRNA encoding all three neurokinin receptors. Immunohistochemical analysis showed NK1 receptor to be located in the interstitial cells of the gland. This location was confirmed by use of in situ hybridization using radioactively labeled antisense oligonucleotide probes. Double immunohistochemical stainings showed that the NK1-immunoreactive cells were not a part of the macrophages or antigen-presenting cells of the gland. Our study suggests that tachykinins, after release from intrapineal nerve fibers, are involved in an up to now unknown function, different from that of melatonin synthesis.

PMID: 15926922 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15869528&query_hl=4

Eur J Neurosci. 2005 Apr;21(8):2297-304.
 
The photoperiod entrains the molecular clock of the rat pineal.

Engel L, Lorenzkowski V, Langer C, Rohleder N, Spessert R.

Department of Anatomy, Johannes Gutenberg University, Saarstrasse 19-21, D-55099 Mainz, Germany.

The suprachiasmatic nucleus-pineal system acts as a neuroendocrine transducer of seasonal changes in the photoperiod by regulating melatonin formation. In the present study, we have investigated the extent to which the photoperiod entrains the nonself-cycling oscillator in the Sprague-Dawley rat pineal. For this purpose, the 24-h expression of nine clock genes (bmal1, clock, per1, per2, per3, cry1, cry2, dec1 and dec2) and the aa-nat gene was monitored under light-dark 8 : 16 and light-dark 16 : 8 in the rat pineal by using real-time RT-PCR. The 24-h pattern of the expression of only per1, dec2 and aa-nat genes was affected by photoperiod. In comparison with the short photoperiod, the duration of elevated expression under the long photoperiod was elongated for per1 and shortened for dec2 and aa-nat. For each of the genes, photoperiod-dependent variations partly persisted under constant darkness. Therefore, the pineal clockwork appears to memorize the photoperiod of prior entrained cycles. The findings of the present study indicate that the nonself-cycling oscillator of the rat pineal is entrained by photoperiodic information and therefore that it participates in seasonal timekeeping.

PMID: 15869528 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15945613&query_hl=4

Magnes Res. 2005 Mar;18(1):19-34.
 
Magnesium depletion with hypo- or hyper- function of the biological clock may be involved in chronopathological forms of asthma.

Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A.

SDRM, Universite Pierre et Marie Curie, 75252 Paris Cedex 05, France. jean.durlach@wanadoo.fr

Asthma is a chronic, inflammatory disorder of the airways leading to airflow limitation. Its worldwide rise, mainly in developed countries, is a matter of concern. Nocturnal asthma (NA) frequently occurs and concerns two thirds of asthmatics. But, it remains controversial whether NA is a distinct entity or is a manifestation of more severe asthma. Generally, it is considered as an exacerbation of the underlying pathology. The pathological mechanisms most likely involve endogenous circadian rhythms with pathological consequences on both respiratory inflammation and hyperresponsiveness. A decrease in blood and tissue magnesium levels is frequently reported in asthma and often testifies to a true magnesium depletion. The link with magnesium status and chronobiology are well established. The quality of magnesium status directly influences the Biological Clock (BC) function, represented by the suprachiasmatic nuclei and the pineal gland. Conversely, BC dysrythmias influence the magnesium status. Two types of magnesium deficits must be clearly distinguished: deficiency corresponding to an insufficient intake which can be corrected through mere nutritional Mg supplementation and depletion due to a dysregulation of the magnesium status which cannot be corrected through nutritional supplementation only, but requires the more or less specific correction of the dysregulation mechanisms. Both in clinical and in animal experiments, the dysregulation mechanisms of magnesium depletion associate a reduced magnesium intake with various types of stress including biological clock dysrhythmias. The differenciation between Mg depletion forms with hyperfunction of BC (HBC) and forms with hypofunction of BC (hBC) is seminal and the main biological marker is melatonin (MT) production alteration. We hypothesize that magnesium depletion with HBC or hBC may be involved in chronopathological forms of asthma. Nocturnal asthma would be linked to HBC, represented by an increase in MT levels. The corresponding clinical forms associate diverse expressions of nervous hypoexcitability such as depression, cluster headaches, dyssomnia, mainly advanced sleep phase syndrome, some clinical forms of chronic fatigue syndrome and of fibromyalgia. The main comorbidities are depression and/or asthenia. They take place during the night or the "bad" seasons (autumn and winter) when sunshine is at a minimum. The corresponding chronopathological therapy relies on bright light phototherapy sometimes with additional psychoanaleptics. Conversely, asthma forms linked to hBC are less frequently studied as a whole and present a decrease in MT levels. They associate various signs of nervous hyperexcitability such as anxiety, diurnal cephalalgia (mainly migraine), dyssomnia, mainly delayed sleep phase syndrome, and some clinical forms of chronic fatigue syndrome and of fibromyalgia. The treatment relies on diverse forms of "darkness therapy", possibly with the help of some psycholeptics. Finally, the treatment of asthma involves the maintenance of a standard dosing schedule of anti-asthma drugs, a balanced magnesium intake and the appropriate treatment of the chronopathological disorders.

PMID: 15945613 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15816940

Epilepsia. 2005 Apr;46(4):473-80.
 
Hippocampal melatonin receptors modulate seizure threshold.

Stewart LS, Leung LS.

Program in Neuroscience, Department of Physiology & Pharmacology, The University of Western Ontario, London, Ontario, Canada. lee.stewart@mcgill.ca

PURPOSE: The pineal hormone melatonin has been shown to enhance hippocampal excitability. We therefore investigated whether inactivation of hippocampal melatonin receptors affects behavioral seizures.
METHODS: Intrahippocampal infusions were performed in rats to study the effect of different melatonin receptor antagonists on behavioral activity, EEG, and seizure susceptibility. Experiments were conducted at 2 times of the day that coincided with the peak and trough of the daily melatonin rhythm.
RESULTS: Local infusion of the Mel(1b) receptor antagonist 4-phenyl-2-propionamidotetralin (4-P-PDOT) into the hippocampus, but not the overlying neocortex, significantly increased seizure latency and in some cases provided complete protection against seizure development. In addition, 4-P-PDOT suppressed open field activity and hippocampal EEG amplitude. The mixed Mel(1a)/Mel(1b) receptor antagonist luzindole also increased seizure latency but to a lesser degree than 4-P-PDOT. The behavioral effects of Mel(1b) receptor inhibition were comparable to those of the gamma-aminobutyric acid (GABA)(A) receptor agonist muscimol and were observed during the dark phase (2400-0200 h) but not the light phase (1200-1400 h) of the daily photocycle. The anticonvulsant effect of intrahippocampal infusion of 4P-P-DOT was blocked by coadministration of the GABA(A) antagonist bicuculline.
CONCLUSIONS: Our results suggest that nocturnal activation of hippocampal Mel(1b) receptors depresses GABA(A) receptor function in the hippocampus and enhances seizure susceptibility.

PMID: 15816940 [PubMed - in process]


From Science Direct

Journal of Neuroimmunology - Volume 161, Issues 1-2 , April 2005, Pages 137-144

Time course and role of the pineal gland in photoperiod control of innate immune cell functions in male Siberian hamsters

Steven M. Yellon (a, b), Kiam Kim (a), Allison R. Hadley (a) and Long T. Tran (a)

(a)Center for Perinatal Biology Research, Department of Physiology, School of Medicine, Loma Linda University Adventist Health Sciences Center, USA
( b) Immunology Research Group, Loma Linda University Adventist Health Sciences Center, Loma Linda, CA, USA

The time course of select phagocyte and natural killer activities to short days was determined. In advance of testes regression, circulating granulocyte and monocyte cell numbers in hamsters decreased while lymphocyte numbers increased; phagocytosis and oxidative burst activity also decreased. To determine whether the pineal gland influences these innate immune cell functions, hamsters were exposed to constant light. Photoperiod control of testes weight and basal oxidative burst activity was abolished by treatment with constant light; other phagocyte activities and leukocyte proportions in circulation were not affected. The findings suggest that photoperiod and pineal gland function may regulate certain innate immune activities.


From Science Direct

Sleep Medicine Reviews Volume 9, Issue 1 , February 2005, Pages 11-24

Physiological review

The basic physiology and pathophysiology of melatonin

Bruno Claustrat (a), Jocelyne Brun (a) and Guy Chazot (b)

(a) Centre de Médecine Nucléaire, Service de Radioanalyse, Hôpital Neuro-Cardiologique, 59 Boulevard Pinel, 69394 Lyon Cedex 03, France
(b) Service de Neurologie, Hôpital Neuro-Cardiologique, Lyon, France

Summary. Melatonin is a methoxyindole synthesized and secreted principally by the pineal gland at night under normal environmental conditions. The endogenous rhythm of secretion is generated by the suprachiasmatic nuclei and entrained to the light/dark cycle. Light is able to either suppress or synchronize melatonin production according to the light schedule. The nycthohemeral rhythm of this hormone can be determined by repeated measurement of plasma or saliva melatonin or urine sulfatoxymelatonin, the main hepatic metabolite.

The primary physiological function of melatonin, whose secretion adjusts to night length, is to convey information concerning the daily cycle of light and darkness to body physiology. This information is used for the organisation of functions, which respond to changes in the photoperiod such as the seasonal rhythms. Seasonal rhythmicity of physiological functions in humans related to possible alteration of the melatonin message remains, however, of limited evidence in temperate areas in field conditions. Also, the daily melatonin secretion, which is a very robust biochemical signal of night, can be used for the organisation of circadian rhythms. Although functions of this hormone in humans are mainly based on correlative observations, there is some evidence that melatonin stabilises and strengthens coupling of circadian rhythms, especially of core temperature and sleep-wake rhythms. The circadian organisation of other physiological functions could depend on the melatonin signal, for instance immune, antioxidative defences, hemostasis and glucose regulation.

Since the regulating system of melatonin secretion is complex, following central and autonomic pathways, there are many pathophysiological situations where the melatonin secretion can be disturbed. The resulting alteration could increase predisposition to disease, add to the severity of symptoms or modify the course and outcome of the disorder.


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15652871

Biol Psychiatry. 2005 Jan 15;57(2):134-8.
 
Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder.

Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y.

Center for Scientific Research, Unite de Recherche Mixte 7593, Vurnerabilite, Adaptation et Psychopathologie, Hopital Pitie-Salpetriere, Centre Hospitalier Guillaume Regnier, Faculte de Medecine Universite de Rennes 1.

BACKGROUND: Many studies in autistic disorder report sleep problems and altered circadian rhythms, suggesting abnormalities in melatonin physiology. Additionally, melatonin, a pineal gland hormone produced from serotonin, is of special interest in autistic disorder given reported alterations in central and peripheral serotonin neurobiology. METHODS: Nocturnal urinary excretion of 6-sulphatoxymelatonin was measured by radioimmunoassay in groups of children and adolescents with autistic disorder (n = 49) and normal control individuals (n = 88) matched on age, sex, and Tanner stage of puberty.
RESULTS: Nocturnal 6-sulphatoxymelatonin excretion rate was significantly and substantially lower in patients with autism than in normal controls (mean +/- SEM, .75 +/- .11 vs. 1.80 +/- .17 mug/hr, p =.0001), and was significantly negatively correlated with severity of autistic impairments in verbal communication and play (p < .05).
CONCLUSIONS: These findings indicate clearly that nocturnal production of melatonin is reduced in autism. Further research is warranted in order to understand the mechanisms underlying the lower melatonin production, to assess the impact of altered melatonin on the pathophysiology and behavioral expression of autistic disorder, and to determine the utility of melatonin administration in individuals with autism.

PMID: 15652871 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15666035

J Neural Transm. 2005 Jan 24; [Epub ahead of print]
 
Antioxidant capacity of the neurohormone melatonin.

Sofic E, Rimpapa Z, Kundurovic Z, Sapcanin A, Tahirovic I, Rustembegovic A, Cao G.

Neuroscience and Phytochemical Laboratories, Jean Mayer USDA Human Nutrition Research Center on Aging, Tuft-s University, and Department of Molecular and Cellular Toxicology, HSPH, Harvard University, Boston, MA, U.S.A..

The aim of this study was to elucidate the antioxidant behaviour of melatonin (M) and determine its activity-structure relationship. M or 5-metoxy-N acetyltriptamine is a neurohormone secreted by the pineal gland, which plays a proven role in maintaining sleep-wake rhythms. The antioxidant capacity of M was analysed using the oxygen radical absorbance capacity (ORAC) assay. Furthermore, spectral measurements for aerobic photolytic reaction of neutral red (NR) and degree of inhibition of photolysis with M, glutathione (GSH), ascorbic acid (AA) and vitamin E analogue Trolox were studied at room temperature 25 degrees C, using visible (VIS) and ultra-violet (UV) radiations. In the ORAC assay 2,2-azobis (2-amidino-propane)dihydrochloride (AAPH) a peroxyl radical generator, ROO degrees ; H(2)O(2)-Cu(2+), mainly a hydroxyl radical generator, degrees OH; and Cu(2+) a transition metal were used. Although some studies indicated that M is a powerful antioxidant, no one has compared its antioxidant capacities with GSH, E-vitamin and AA, using three free radical (FR) generators in an assay which utilizes an area-under curve technique and thus combines both inhibition time and inhibition degree of FR action by an antioxidant into a single quantity. In the current study, we used ORAC assay with three FR generators. The assay is based on propensity of the fluorescence emitted by the protein beta-phycoerythrin (beta-PE) from porphyridium cruentum to be quenched when exposed to FR action. M in our experiments acted as a universal antioxidant against ROO degrees and degrees OH radicals. Also, M served as an antioxidant in the presence of Cu(2+). M, which is a lipid-soluble compound, was a twice more powerful antioxidant than vitamin E, and four times than AA or GSH. Furthermore, M inhibited aerobic photolysis of NR photoinduced with VIS and UV rays faster and more effectively, than AA, GSH or vitamin E. AA with NR, under aerobic conditions during irradiation with VIS and UV acted as a pro-oxidant.M may be the premier molecule to protect the cells from oxidative stress.

PMID: 15666035 [PubMed - as supplied by publisher]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15621008

Brain Res. 2005 Jan 7;1031(1):10-9.
 
Melatonin modulates intercellular communication among cultured chick astrocytes.

Peters JL, Cassone VM, Zoran MJ.

Department of Biology and Center for Biological Clocks Research, Texas A&M University, Room 231, College Station, TX 77843-3258, USA.

Melatonin, a pineal neurohormone, mediates circadian and seasonal processes in birds and mammals. Diencephalic astrocytes are sites of action, at least in birds, since they express melatonin receptors and melatonin affects their metabolism. We tested whether astrocytic calcium waves are also modulated by melatonin. Calcium waves, which we found to be regulated in cultured chick glial cells by an IP(3)-dependent mechanism, were potentiated by physiological concentrations of melatonin. Melatonin also increased resting calcium levels and reduced gap junctional coupling among astrocytes, at concentrations that facilitated calcium waves. These modulatory effects were diminished by melatonin receptor blockade and pertussis toxin (PTX). Thus, melatonin induced a functional shift in the mode of intercellular communication, between junctional coupling and calcium waves, among glial cells. We suggest a mechanism where neuroglial physiology, involving GTP-binding protein signaling pathways, links rhythmic circadian outputs to pervasive neurobehavioral states.

PMID: 15621008 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15649735

Sleep Med Rev. 2005 Feb;9(1):11-24.
 
The basic physiology and pathophysiology of melatonin.

Claustrat B, Brun J, Chazot G.

Centre de Medecine Nucleaire, Service de Radioanalyse, Hopital Neuro-Cardiologique, 59 Boulevard Pinel, 69394 Lyon Cedex 03, France.

Melatonin is a methoxyindole synthesized and secreted principally by the pineal gland at night under normal environmental conditions. The endogenous rhythm of secretion is generated by the suprachiasmatic nuclei and entrained to the light/dark cycle. Light is able to either suppress or synchronize melatonin production according to the light schedule. The nycthohemeral rhythm of this hormone can be determined by repeated measurement of plasma or saliva melatonin or urine sulfatoxymelatonin, the main hepatic metabolite. The primary physiological function of melatonin, whose secretion adjusts to night length, is to convey information concerning the daily cycle of light and darkness to body physiology. This information is used for the organisation of functions, which respond to changes in the photoperiod such as the seasonal rhythms. Seasonal rhythmicity of physiological functions in humans related to possible alteration of the melatonin message remains, however, of limited evidence in temperate areas in field conditions. Also, the daily melatonin secretion, which is a very robust biochemical signal of night, can be used for the organisation of circadian rhythms. Although functions of this hormone in humans are mainly based on correlative observations, there is some evidence that melatonin stabilises and strengthens coupling of circadian rhythms, especially of core temperature and sleep-wake rhythms. The circadian organisation of other physiological functions could depend on the melatonin signal, for instance immune, antioxidative defences, hemostasis and glucose regulation. Since the regulating system of melatonin secretion is complex, following central and autonomic pathways, there are many pathophysiological situations where the melatonin secretion can be disturbed. The resulting alteration could increase predisposition to disease, add to the severity of symptoms or modify the course and outcome of the disorder.

PMID: 15649735 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15683466

J Pineal Res. 2005 Mar;38(2):116-22.
 
Demonstration of PACAP-immunoreactive intrapineal nerve fibers in the golden hamster (Mesocricetus auratus) originating from the trigeminal ganglion.

Baeres FM, Moller M.

Institute of Medical Anatomy, Panum Institute, University of Copenhagen, Copenhagen, Denmark.

By using immunohistochemistry, a network of nerve fibers containing pituitary adenylate-cyclase activating polypeptide (PACAP) was demonstrated in the pineal gland of the golden hamster, a photoperiodic species often used in pineal and circadian rhythm research. The nerve fibers are present in the capsule from where they permeate into the pineal perivascular spaces and parenchyma. Immuno-electron microscopy showed the PACAPergic nerve terminals, with clear transmitter vesicles, to terminate in the interstitial spaces between the pinealocytes or in the perivascular spaces. Some of the PACAPergic nerve terminals made synapse-like contacts with the pinealocytes. The origin of the PACAP-containing nerve fibers innervating the pineal gland of the hamster was investigated by combined retrograde tracing with fluorogold and immunohistochemistry for PACAP. A 2% fluorogold solution was injected iontophoretically into the superficial pineal gland and the animals were allowed to survive for 1 wk. After perfusion fixation of the rats, the location of the tracer was investigated in the brain, the parasympathetic sphenopalatine, and otic ganglia, as well as in the sensory trigeminal ganglia. The tracer was found in perikarya of all the investigated ganglia. However, co-localization with PACAP was found only in the trigeminal ganglion.

PMID: 15683466 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15683461

J Pineal Res. 2005 Mar;38(2):73-83.

Melatonin as an organoprotector in the stomach and the pancreas.

Jaworek J, Brzozowski T, Konturek SJ.

Department of Physiology, Jagiellonian University College of Medicine, Cracow, Poland.

Melatonin was thought to originate primarily from the pineal gland and to be secreted during the night, but recent studies revealed that gastrointestinal (GI) tract presents another, many times larger, source of melatonin that contributes significantly to the circulating concentration of this indole. Melatonin may exert a direct effect on GI tissues but its major influence on GI organs seems to occur indirectly, via the brain-gut axis including peripheral receptors, sensory afferent (vagal or sympathetic) pathways and central nervous system (CNS) acting on these organs via autonomic efferents and neuromediators. This article reviews and updates our experience with the fascinating molecule, as related to GI organs, with special focus on secretory activity of the stomach and pancreas and the maintenance of their tissue integrity. In addition to being released into the circulation, melatonin is also discharged into the gut lumen and this appears to be implicated in the postprandial stimulation of pancreatic enzyme secretion, mediated by melatonin-induced release of cholecystokinin, acting through entero-gastro-pancreatic reflexes. Although exerting certain differences in the mechanism of action on gastric and pancreatic secretory activities, melatonin derived from its precursor l-tryptophan, exhibits similar highly protective actions against the damage of both the stomach and the pancreas and accelerates the healing of chronic gastric ulcerations by stimulating the microcirculation and cooperating with arachidonate metabolites such as prostaglandins, with nitric oxide released from vascular endothelium, and/or sensory nerves and with their neuropeptides such as calcitonin gene related peptide. The beneficial effects of melatonin results in gastro- and pancreato-protection, prevents various forms of gastritis and pancreatitis through the activation of specific MT(2)-receptors and scavenges reactive oxygen species (ROS). Melatonin counteracts the increase in the ROS-induced lipid peroxidation and preserves, at least in part, the activity of key anti-oxidizing enzymes such as superoxide dismutase. It is proposed that melatonin should be considered as the agent exerting an important role in prevention of gastric and pancreatic damage and in accelerating healing of gastric ulcers.

PMID: 15683461 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15589043

J Neuroimmunol. 2005 Jan;158(1-2):106-11.

Does melatonin play a disease-promoting role in rheumatoid arthritis?

Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR.

Center for Experimental Pathology, Cantonal Institute of Pathology, Via In Selva 24, P.O. Box 6601 Locarno, Switzerland.

The pineal neurohormone melatonin (MLT) has been widely shown to exert an immunostimulatory and antiapoptotic role, mainly by acting on Th cells and on T and B cell precursors, respectively. Thus, MLT might favor or promote autoimmune diseases by acting directly on immature and mature immunocompetent cells. In fact, preclinical and clinical evidence point to a disease-promoting role of MLT in rheumatoid arthritis (RA). MLT, whose concentration is increased in serum from RA patients, may act systemically or locally in the inflamed joints. The circadian secretion of MLT with a peak level during the night hours might be strictly correlated with the peculiar daily rhythmicity of the RA symptoms. In rat studies employing Freund's complete mycobacterial adjuvant (FCA) as a model of rheumatoid arthritis, pinealectomized rats turned arthritic and exhibited a significantly less pronounced inflammatory response, which was restored to normal by a low MLT dose and was aggravated by a pharmacological MLT dose, that augmented the inflammatory and immune response. Continued investigation will refine our understanding of these observations, which will possibly translate into improved therapeutic approaches.

PMID: 15589043 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15607834

Brain Res Bull. 2005 Jan 15;64(5):455-61.

Attenuation of gonadal response to photostimulation following ablation of neurons in the lateral septal organ of chicks.

Rathinam T, Kuenzel WJ.

Poultry Science Center, 1260 W Maple St, University of Arkansas, Fayetteville, AR 72701, USA.

Many avian species in temperate zones respond to long photoperiods by showing recrudescence of gonads. Compelling evidence show that non-retinal, non-pineal photoreceptors exist in the avian brain. Within the ventral forebrain are specialized neurons that respond to light found in the medial portion of a circumventricular organ called the lateral septal organ (LSO). The objective of this study was to examine whether the integrity of the LSO was critical for rapid gonadal development in young male chicks placed under long day photostimulation. Birds were initially kept on a short photoperiod (LD 8:16) until 2 weeks of age, at which time bilateral electrolytic lesions were administered to the LSO. After surgery, birds were transferred to a long photoperiod (LD 16:8) and fed a chick starter diet containing 0.2% sulfamethazine (SMZ). The combination of a long day plus SMZ is known to stimulate sexual maturation in male chicks. In four separate experiments conducted to date, bilateral lesions directed to the LSO and lesions that missed and were placed caudal and ventral to the target resulted in a significant decrease in testes weight, compared to sham-operated controls (P<0.05). Results suggest that neurons in the LSO may be directly involved in responding to long photoperiods and stimulating gonadal development in broiler chicks.

PMID: 15607834 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15607825

Brain Res Bull. 2005 Jan 15;64(5):371-380.

Role of the pineal gland and melatonin in the photoperiodic control of hypothalamic gonadotropin-releasing hormone in the male jerboa (Jaculus orientalis), a desert rodent.

El Qandil S, Chakir J, El Moussaouiti R, Oukouchoud R, Rami N, Benjelloun WA, Lakhdar-Ghazal N.

Department de Biologie, Unite de Neurosciences, Faculte des Sciences, Groupe de Recherche sur les Rythmes Biologiques, Universite Mohammed V, BP. 1014, avenue Ibn Battouta 10000 Rabat, Morocco; Laboratoire de Physiologie Animale, Faculte des Sciences, Universite Hassan II-Mohammedia, Casablanca, Morocco.

The neuroendocrine mechanism underlying seasonal changes in gonadal activity of the jerboa, a desert hibernating rodent adapted to harsh climatic conditions, are poorly understood. We investigated the role of the pineal gland and melatonin in the photoperiodic control of hypothalamic gonadotropin-releasing hormone (GnRH). Intact and pinealectomized male jerboas were subjected to short photoperiod, while others were kept under long photoperiod and injected daily with melatonin or vehicle. Testes activity was monitored by evaluating the testes volume during 10 weeks. GnRH immunoreactivity was investigated quantitatively with image analysis. Following melatonin administration, the hormone peaked in plasma after 30min, with return to control levels 2.5h later. Exposure to short photoperiod and melatonin resulted in marked increase in the number of GnRH-containing cells in the preoptic area and mediobasal hypothalamus, whereas GnRH immunoreactivity of fibers and terminals in the median eminence decreased under these conditions. The findings indicate that in the jerboa short photoperiod induces testicular regression by prolonging the duration of melatonin as an endocrine signal. This mechanism probably involves inhibition of GnRH release in the median eminence, with consequent accumulation of GnRH in perikarya of the preoptic area and mediobasal hypothalamus. Interestingly, GnRH cells of the median eminence did not appear to be influenced by the photoperiod and pineal melatonin, whereas their number was increased by exogenous melatonin. The latter data suggest for the first time the involvement of an extrapineal melatonin, whose origin remains to be identified, in the modulation of the GnRH regulatory system in rodents.

PMID: 15607825 [PubMed - as supplied by publisher]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15606905

J Neurochem. 2005 Jan;92(1):158-70.

Molecular cloning, localization and circadian expression of chicken melanopsin (Opn4): differential regulation of expression in pineal and retinal cell types.

Chaurasia SS, Rollag MD, Jiang G, Hayes WP, Haque R, Natesan A, Zatz M, Tosini G, Liu C, Korf HW, Iuvone PM, Provencio I.

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.

The avian retina and pineal gland contain autonomous circadian oscillators and photo-entrainment pathways, but the photopigment(s) that mediate entrainment have not been definitively identified. Melanopsin (Opn4) is a novel opsin involved in entrainment of circadian rhythms in mammals. Here, we report the cDNA cloning of chicken melanopsin and show its expression in retina, brain and pineal gland. Like the melanopsins identified in amphibians and mammals, chicken melanopsin is more similar to the invertebrate retinaldehyde-based photopigments than the retinaldehyde-based photopigments typically found in vertebrates. In retina, melanopsin mRNA is expressed in cells of all retinal layers. In pineal gland, expression was strong throughout the parenchyma of the gland. In brain, expression was observed in a few discrete nuclei, including the lateral septal area and medial preoptic nucleus. The retina and pineal gland showed distinct diurnal expression patterns. In pineal gland, melanopsin mRNA levels were highest at night at Zeitgeber time (ZT) 16. In contrast, transcript levels in the whole retina reached their highest levels in the early morning (ZT 0-4). Further analysis of melanopsin mRNA expression in retinal layers isolated by laser capture microdissection revealed different patterns in different layers. There was diurnal expression in all retinal layers except the ganglion cell layer, where heavy expression was localized to a small number of cells. Expression of melanopsin mRNA peaked during the daytime in the retinal pigment epithelium and inner nuclear layer but, like in the pineal, at night in the photoreceptors. Localization and regulation of melanopsin mRNA in the retina and pineal gland is consistent with the hypothesis that this novel photopigment plays a role in photic regulation of circadian function in these tissues.

PMID: 15606905 [PubMed - in process]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15617533

J Pineal Res. 2005 Jan;38(1):17-26.

Reactive changes of interstitial glia and pinealocytes in the rat pineal gland challenged with cell wall components from gram-positive and -negative bacteria.

Jiang-Shieh YF, Wu CH, Chien HF, Wei IH, Chang ML, Shieh JY, Wen CY.

Department of Anatomy, College of Medicine, National Cheng Kung University, Tainan.

Lipopolysaccharide (LPS), the major proinflammatory component of gram-negative bacteria, is well known to induce sepsis and microglial activation in the CNS. On the contrary, the effect of products from gram-positive bacteria especially in areas devoid of blood-brain barrier remains to be explored. In the present study, a panel of antibodies, namely, OX-6, OX-42 and ED-1 was used to study the response of microglia/macrophages in the pineal gland of rats given an intravenous LPS or lipoteichoic acid (LTA). These antibodies recognize MHC class II antigens, complement type 3 receptors and unknown lysosomal proteins in macrophages, respectively. In rats given LPS (50 mug/kg) injection and killed 48 h later, the cell density and immunoexpression of OX-6, OX-42 and ED-1 in pineal microglia/macrophages were markedly increased. In rats receiving a high dose (20 mg/kg) of LTA, OX-42 and OX-6, immunoreactivities in pineal microglia/macrophages were also enhanced, but that of ED-1 was not. In addition, both bacterial toxins induced an increase in astrocytic profiles labelled by glial fibrillary acid protein. An interesting feature following LPS or LTA treatment was the lowering effect on serum melatonin, enhanced serotonin immunolabelling and cellular vacuolation as studied by electron microscopy in pinealocytes. The LPS- or LTA-induced vacuoles appeared to originate from the granular endoplasmic reticulum as well as the Golgi saccules. The present results suggest that LPS and LTA could induce immune responses of microglia/macrophages and astroglial activation in the pineal gland. Furthermore, the metabolic and secretory activity of pinealocytes was modified by products from both gram-positive and -negative bacteria.

PMID: 15617533 [PubMed - as supplied by publisher]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15544844

Regul Pept. 2005 Jan 15;124(1-3):81-7.
 
Expression of orexin receptors in the brain and peripheral tissues of the male sheep.

Zhang S, Blache D, Vercoe PE, Adam CL, Blackberry MA, Findlay PA, Eidne KA, Martin GB.

Faculty of Natural and Agricultural Sciences, School of Animal Biology, University of Western Australia, 35 Stirling Highway, Perth, Crawley 6009, Australia.

Orexins exert their effects through two specific receptors (OX1R and OX2R) that have been found mainly in the brain and also in peripheral tissues of rats and humans. Here, we demonstrate expression of mRNA encoding for ovine OX1R and OX2R in central and peripheral tissues of sheep. Gene expression for orexin receptors in the hypothalamus and the preoptic area was localised by in situ hybridisation. OX1R was detected in arcuate nuclei (ARC), median eminence (ME), the lateral hypothalamic nuclei and preoptic area (POA) and it was scattered along the third ventricle from the paraventricular (PVN) to the ventromedial hypothalamic nuclei (VMH). OX2R was localised in the PVN, ARC, ME, ventral VMH and a small region of the ventral POA. Gene expression for OX1R and OX2R in central and peripheral tissues was analysed using quantitative real time RT-PCR. Both orexin receptor genes were expressed in the hypothalamus, POA, hippocampus, amygdala, olfactory bulb, pineal gland and recess and pituitary gland, whereas only OX1R mRNA was detected in the testis, kidney and adrenal gland. The expression of the genes for orexin receptors in this range of ovine tissues suggests roles for orexins in multiple physiological functions, with actions at both central and peripheral levels.

PMID: 15544844 [PubMed - in process]

 
Fluoride Action Network | Pesticide Project | 315-379-9200 | pesticides@fluoridealert.org